It was also demonstrated, that atomoxetine which is an orally administered medicine used for the treatment of ADHD resulted in the significant up-regulation of SNAP-25 both on mRNA and protein level [38]. The gene discussed is SNAP25; the disease is attention deficit-hyperactivity disorder.